🇺🇸 FDA
Pipeline program

Medpulser electroporation with Bleomycin

HNBE-03-01

Approved other terminated

Quick answer

Medpulser electroporation with Bleomycin for Head and Neck Cancer is a Approved program (other) at INOVIO PHARMACEUTICALS, INC. with 2 ClinicalTrials.gov record(s).

Program details

Company
INOVIO PHARMACEUTICALS, INC.
Indication
Head and Neck Cancer
Phase
Approved
Modality
other
Status
terminated

Clinical trials